(Q37807503)

English

Detecting and treating hyperlipidemia in children with type 1 diabetes mellitus: are standard guidelines applicable to this special population?

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 August 2017

Detecting and treating hyperlipidemia in children with type 1 diabetes mellitus: are standard guidelines applicable to this special population? (English)

1 reference

Europe PubMed Central

23 August 2017

type-1 diabetes

0 references

1 reference

based on heuristic

inferred from title

author name string

Nicole S Glaser

1

1 reference

Europe PubMed Central

23 August 2017

David H Geller

2

1 reference

Europe PubMed Central

23 August 2017

Andrea Haqq

3

1 reference

Europe PubMed Central

23 August 2017

Stephen Gitelman

4

1 reference

Europe PubMed Central

23 August 2017

Mary Malloy

5

1 reference

Europe PubMed Central

23 August 2017

Lawson Wilkins Pediatric Endocrine Society Committee on Drugs and Therapeutics

6

1 reference

Europe PubMed Central

23 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

5 November 2010

1 reference

Europe PubMed Central

23 August 2017

Pediatric Diabetes

1 reference

Europe PubMed Central

23 August 2017

12

1 reference

Europe PubMed Central

23 August 2017

4 Pt 2

1 reference

Europe PubMed Central

23 August 2017

442-459

1 reference

Europe PubMed Central

23 August 2017

Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Pathobiological determinants of atherosclerosis in youth risk scores are associated with early and advanced atherosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

PDAY risk score predicts advanced coronary artery atherosclerosis in middle-aged persons as well as youth

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Usefulness of childhood non-high density lipoprotein cholesterol levels versus other lipoprotein measures in predicting adult subclinical atherosclerosis: the Bogalusa Heart Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Risk factors identified in childhood and decreased carotid artery elasticity in adulthood: the Cardiovascular Risk in Young Finns Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: the Muscatine Study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Coronary artery disease in IDDM. Gender differences in risk factors but not risk.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Progression of coronary artery calcification in type 1 diabetes: the importance of glycemic control

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Carotid artery intima-media thickness in children with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Early onset of subclinical atherosclerosis in young persons with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Longitudinal screening of serum lipids in children and adolescents with Type 1 diabetes in a UK clinic population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Lipid abnormalities are prevalent in youth with type 1 and type 2 diabetes: the SEARCH for Diabetes in Youth Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: a population-based study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Spectrum and prevalence of atherogenic risk factors in 27,358 children, adolescents, and young adults with type 1 diabetes: cross-sectional data from the German diabetes documentation and quality management system (DPV).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Awareness and treatment of dyslipidemia in young adults with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Screening and treatment for lipid disorders in children and adolescents: systematic evidence review for the US Preventive Services Task Force

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Serum lipids and glucose control: the SEARCH for Diabetes in Youth study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Prevalence and determinants of elevated apolipoprotein B and dense low-density lipoprotein in youths with type 1 and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications Trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Lipid and lipoprotein profiles in youth with and without type 1 diabetes: the SEARCH for Diabetes in Youth case-control study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Total cholesterol and high-density lipoprotein levels in pediatric subjects with type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

The cardiovascular risk profile of adolescents with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Cellular cholesterol efflux to plasma from moderately hypercholesterolaemic type 1 diabetic patients is enhanced, and is unaffected by simvastatin treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

HDL composition predicts new-onset cardiovascular disease in patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Plasma levels of HDL subpopulations and remnant lipoproteins predict the extent of angiographically-defined coronary artery disease in postmenopausal women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Hyperglycemia and plasma lipid levels: a prospective study of young insulin-dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Hyperglycemia and plasma lipid levels: covariations in insulin-dependent diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Apo(B)-dependent dyslipidemic phenotypes in type 1 diabetic patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Low-density lipoprotein particle size and coronary artery disease in a childhood-onset type 1 diabetes population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Glycemic control, oxidative stress, and lipid profile in children with type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Québec Cardiovascular Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Smallest LDL particles are most strongly related to coronary disease progression in men.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Concomitant reduction of low-density lipoprotein-cholesterol and biomarkers of inflammation with low-dose simvastatin therapy in patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Sensitivity and specificity of pediatric lipid determinations for adult lipid status: findings from the Princeton Lipid Research Clinics Prevalence Program Follow-up Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Year-to-year variability of cholesterol levels in a pediatric practice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

The use of statins in pediatrics: knowledge base, limitations, and future directions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Statin treatment for children and adolescents with heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

A randomized crossover trial of combination pharmacologic therapy in children with familial hyperlipidemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Statin safety and drug interactions: clinical implications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Comparative tolerability of the HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Statin myopathy: incidence, risk factors, and pathophysiology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Statin-associated myopathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

The creatine kinase response to eccentric exercise with atorvastatin 10 mg or 80 mg.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Functional analysis of a mutation in the SLCO1B1 gene (c.1628T>G) identified in a Japanese patient with pravastatin-induced myopathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Genetic predisposition to statin myopathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Gestational exposure to lovastatin followed by cardiac malformation misclassified as holoprosencephaly

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Developmental roles and clinical significance of hedgehog signaling

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

An assessment of statin safety by neurologists.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Conceptual foundations of the UCSD Statin Study: a randomized controlled trial assessing the impact of statins on cognition, behavior, and biochemistry

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Cognitive impairment associated with atorvastatin and simvastatin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Randomized trial of the effects of simvastatin on cognitive functioning in hypercholesterolemic adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Statins and cancer risk: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Lipid screening and cardiovascular health in childhood

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Cardiovascular Risk Factors in Childhood and Carotid Artery Intima-Media Thickness in Adulthood

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Prevalence and Phenotypic Distribution of Dyslipidemia in Type 1 Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00709.X

21 January 2018

Identifiers

10.1111/J.1399-5448.2010.00709.X

1 reference

Europe PubMed Central

23 August 2017

1 reference

Europe PubMed Central

23 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37807503&oldid=1634695258"